Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years - 80 Years|
- - Patients with rheumatoid arthritis (RA) meeting the classification criteria of American College of Rheumatology (ACR) and/or European League Against Rheumatism (EULAR) från 2010.
- - Patients with psoriatic arthritis (PsA) meeting the classification criteria of Classification for Psoriatic Arthritis (CASPAR) PsA.
- - Patients with undifferentiated arthritis defined as a patients with a clear arthritis, but not meeting with established classifications criteria of any now known rheumatic disease.
- - Patients with psoriasis diagnosed at a dermatology department.
- - General population controls, matched for age, sex and residence of living to the included patients.
- - Inability to follow study protocol.
- - Swedish language difficulties.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
|Vastra Gotaland Region|
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Eva Klingberg, Assoc. ProfInger Gjertsson, Prof|
|Principal Investigator Affiliation||Dep of Rheumatology and Inflammation research, University of Gothenburg, SwedenDep of Rheumatology and Inflammation research, University of Gothenburg, Sweden|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
|Rheumatoid Arthritis, Psoriatic Arthritis, Arthritis, Psoriasis, Cardiovascular Diseases, Obesity, Lung Diseases|
: Patients with rheumatoid arthritis (RA)
Patients with RA meeting the classification criteria of American College of Rheumatology (ACR) and/or European League Against Rheumatism (EULAR) från 2010.
: Patients with psoriatic arthritis (PsA)
Patients with PsA meeting the classification criteria of Classification for Psoriatic Arthritis (CASPAR).
: Patients with undifferentiated arthritis
Defined as a patients with a clear arthritis, but not meeting with established classifications criteria of any now known rheumatic disease.
: Patients with psoriasis
Patients with psoriasis diagnosed at a dermatology department. The patients should not have any history of joint complaints with a duration of more than 6 weeks.
: General population controls
General population controls retrieved from the Population Register, matched for age, sex and residence of living to the included patients.
Other: - Care as usual
No intervention will be given. The study will follow the effects of care as usual.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.